Health Care Delivery

Latest News

Roflumilast cream | Image Credit: © luchschenF-stock.adobe.com
Roflumilast Cream 0.05% Durable, Safe for Younger Pediatric Patients

August 15th 2025

The INTEGUMENT-OLE study is an open-label extension analysis that followed a primary investigation from the phase 3 INTEGUMENT-PED trial, which investigated the efficacy and safety of once-daily roflumilast cream 0.05% for atopic dermatitis in children aged 2 to 5 years.

Paper saying Medicaid eligibility | Image credit: Vitalii Vodolazskyi – stock.adobe.com
5 Key Takeaways on Medicaid Policy Changes From Savista’s Chief Strategy Officer

August 15th 2025

The researchers noted diabetes and hypertension are both modifiable with appropriate management that brings patients to guidelines-based targets. | Image Credit: Crystal light - stock.adobe.com
PCPs Have Unique Opportunity to Detect, Manage CKD

August 14th 2025

Older adult holding several pills and glass of water | Image credit: Kotchakorn – stock.adobe.com
Polypharmacy Common in Rheumatoid Arthritis, Driving Risk of Serious Drug Interactions

August 13th 2025

Doctor pointing to model gallbladder | Image credit: Peakstock – stock.adobe.com
Gallbladder Removal With 3-Plus Risk Factors May Increase MASLD Risk

August 13th 2025

More News

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo